Optiver Holding’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-1,900
Closed -$77.2K – 710
2023
Q4
$77.2K Sell
1,900
-6,400
-77% -$236K ﹤0.01% 417
2023
Q3
$287K Sell
8,300
-67,200
-89% -$2.62M ﹤0.01% 428
2023
Q2
$3.07M Sell
75,500
-16,700
-18% -$681K ﹤0.01% 338
2023
Q1
$3.56M Buy
92,200
+9,800
+12% +$403K ﹤0.01% 340
2022
Q4
$3.66M Sell
82,400
-127,900
-61% -$5.38M ﹤0.01% 288
2022
Q3
$8.97M Buy
210,300
+46,600
+28% +$2.39M 0.01% 193
2022
Q2
$9.13M Sell
163,700
-39,600
-19% -$2.35M 0.01% 172
2022
Q1
$12.6M Sell
203,300
-40,900
-17% -$2.5M 0.01% 139
2021
Q4
$13M Buy
244,200
+77,300
+46% +$4.03M 0.01% 161
2021
Q3
$8.78M Sell
166,900
-8,600
-5% -$511K 0.01% 148
2021
Q2
$12.1M Buy
+175,500
New +$13.4M 0.02% 111
2021
Q1
– Hold
0
– – – 71

Other funds holding LKFT

Optiver Holding's LKFT Position: Q3 2026 in Review

Optiver Holding opened a new position in Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2026: 3,428 shares worth $102K. The stake represents ﹤0.01% of the portfolio and ranks #1005 among its holdings. This is a return to the name: Optiver Holding previously reported a position in LKFT as recently as Q1 2026.

Optiver Holding first reported a position in LKFT in Q2 2021 and has held it in 16 quarters since. The position peaked at $17.4M in Q2 2022. 95 funds tracked by Wall St. Rank hold LKFT as of Q3 2026.

  • Optiver Holding held 3,428 shares of Lakefront Biotherapeutics American Depositary Shares worth $102K as of Q3 2026.
  • Lakefront Biotherapeutics American Depositary Shares was a new Optiver Holding position in Q3 2026.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Optiver Holding's portfolio in Q3 2026, its #1005 holding.
  • Optiver Holding first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2021 and has held it in 16 quarters since.
  • Optiver Holding's Lakefront Biotherapeutics American Depositary Shares position peaked at $17.4M in Q2 2022.
  • 95 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2026.

Based on Optiver Holding's 13F filing for Q3 2026, filed 16 Nov 2026.